XETRA - Delayed Quote EUR

Newron Pharmaceuticals S.p.A. (NP5.DE)

Compare
7.90 -0.32 (-3.89%)
As of 3:03:58 PM GMT+1. Market Open.
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
9,057.00
9,057.00
6,094.00
5,762.00
5,258.00
Cost of Revenue
--
--
--
--
295.00
Gross Profit
--
--
--
--
4,963.00
Operating Expense
20,686.00
20,686.00
19,396.00
18,119.00
23,324.00
Operating Income
-11,629.00
-11,629.00
-13,302.00
-12,357.00
-18,066.00
Net Non Operating Interest Income Expense
-4,501.00
-4,501.00
-4,291.00
-2,730.00
-1,384.00
Pretax Income
-16,200.00
-16,200.00
-17,472.00
-14,884.00
-19,618.00
Tax Provision
24.00
24.00
21.00
17.00
1,380.00
Net Income Common Stockholders
-16,224.00
-16,224.00
-17,493.00
-14,901.00
-20,998.00
Diluted NI Available to Com Stockholders
-16,224.00
-16,224.00
-17,493.00
-14,901.00
-20,998.00
Basic EPS
-0.91
-0.91
-0.98
-0.84
-1.18
Diluted EPS
-0.91
-0.91
-0.98
-0.84
-1.18
Basic Average Shares
17,845.00
17,845.00
17,845.00
17,845.00
17,845.00
Diluted Average Shares
17,845.00
17,845.00
17,845.00
17,845.00
17,845.00
Total Operating Income as Reported
-11,629.00
-11,629.00
-13,302.00
-12,357.00
-18,066.00
Rent Expense Supplemental
98.00
98.00
160.00
115.00
80.00
Total Expenses
20,686.00
20,686.00
19,396.00
18,119.00
23,324.00
Net Income from Continuing & Discontinued Operation
-16,224.00
-16,224.00
-17,493.00
-14,901.00
-20,998.00
Normalized Income
-16,224.00
-16,224.00
-17,493.00
-14,901.00
-20,998.00
Interest Income
179.00
179.00
56.00
54.00
61.00
Interest Expense
4,168.00
4,168.00
3,947.00
2,918.00
2,239.00
Net Interest Income
-4,501.00
-4,501.00
-4,291.00
-2,730.00
-1,384.00
EBIT
-12,032.00
-12,032.00
-13,525.00
-11,966.00
-17,379.00
EBITDA
-11,831.00
-11,831.00
-13,323.00
-11,757.00
-17,160.00
Reconciled Cost of Revenue
--
--
--
--
295.00
Reconciled Depreciation
201.00
201.00
202.00
209.00
219.00
Net Income from Continuing Operation Net Minority Interest
-16,224.00
-16,224.00
-17,493.00
-14,901.00
-20,998.00
Normalized EBITDA
-11,831.00
-11,831.00
-13,323.00
-11,757.00
-17,160.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
12/31/2020 - 7/4/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BIO3.DE Biotest Aktiengesellschaft
26.80
0.00%
 
88Q.DE 4basebio PLC
14.60
0.00%
 
BIO.DE Biotest Aktiengesellschaft
41.40
0.00%
 
9VC.DE Atai Life Sciences N.V.
1.4070
0.00%
 
T5O0.DE bioXXmed AG
1.4850
0.00%
 
7V0.DE Darwin AG
27.40
+0.74%
 
VX1.DE Vertex Pharmaceuticals Incorporated
446.15
+1.09%
 
2L9.SG Blueprint Medicines Corp
89.04
-1.33%
 
4KB.F Krystal Biotech, Inc.
180.40
+2.73%
 
PSH.DE Sernova Corp.
0.1527
-7.34%